pS2 Rabbit Polyclonal Antibody
To Order Contact Us Below:
 ELISA Kit) Human Presenilin 2 (PS2) ELISA Kit |
|
RD-PS2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 600 |
Human Presenilin 2 (PS2) ELISA Kit |
|
RD-PS2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 830.4 |
 ELISA Kit) Rat Presenilin 2 (PS2) ELISA Kit |
|
RD-PS2-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 640.8 |
Rat Presenilin 2 (PS2) ELISA Kit |
|
RD-PS2-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 890.4 |
Human Presenilin 2 (PS2) ELISA Kit |
|
RDR-PS2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 626.4 |
Human Presenilin 2 (PS2) ELISA Kit |
|
RDR-PS2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 868.8 |
Rat Presenilin 2 (PS2) ELISA Kit |
|
RDR-PS2-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 669.6 |
Rat Presenilin 2 (PS2) ELISA Kit |
|
RDR-PS2-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 931.2 |
 pS2 Polyclonal Antibody |
|
ES8664-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against pS2 from Human. This antibody is tested and validated for IHC, WB, ELISA |
pS2 Polyclonal Antibody |
|
ES8664-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against pS2 from Human. This antibody is tested and validated for IHC, WB, ELISA |
pS2 Polyclonal Antibody |
|
46797-100ul |
SAB |
100ul |
EUR 302.4 |
pS2 Polyclonal Antibody |
|
46797-50ul |
SAB |
50ul |
EUR 224.4 |
pS2 Polyclonal Antibody |
|
ABP60016-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of pS2 from Human. This pS2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human pS2 protein at amino acid sequence of 10-50 |
pS2 Polyclonal Antibody |
|
ABP60016-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of pS2 from Human. This pS2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human pS2 protein at amino acid sequence of 10-50 |
pS2 Polyclonal Antibody |
|
ABP60016-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of pS2 from Human. This pS2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human pS2 protein at amino acid sequence of 10-50 |
 Polyclonal TFF1 / pS2 Antibody |
|
AMM08169G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TFF1 / pS2 . This antibody is tested and proven to work in the following applications: |
 pS2 Polyclonal Conjugated Antibody |
|
C46797 |
SAB |
100ul |
EUR 476.4 |
 Rabbit PS2 ELISA Kit |
|
ERTP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 PS2 antibody |
|
70R-50469 |
Fitzgerald |
100 ul |
EUR 292.8 |
|
Description: Purified Polyclonal PS2 antibody |
 Antibody) pS2(GE2) Antibody |
|
BNCA0677-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against pS2(GE2), APC conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCAP0677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCAP0677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC610677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF660R conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC610677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF660R conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCR0677-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against pS2(GE2), RPE conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNUB0677-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against pS2(GE2), Concentration: 0.2mg/mL |
pS2(GE2) Antibody |
|
BNUB0677-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against pS2(GE2), Concentration: 0.2mg/mL |
pS2(GE2) Antibody |
|
BNC430677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF543 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC430677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF543 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC400677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF640R conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC400677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF640R conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC880677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF488A conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC880677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF488A conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC810677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF680R conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC810677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF680R conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCH0677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCH0677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCP0677-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against pS2(GE2), PerCP conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNUM0677-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against pS2(GE2), 1mg/mL |
pS2(GE2) Antibody |
|
BNC050677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF405M conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC050677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF405M conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC680677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF568 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC680677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF568 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC700677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF770 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC700677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF770 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC800677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF680 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC800677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF680 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCB0677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), Biotin conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNCB0677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), Biotin conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC940677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF594 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC940677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF594 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC550677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF555 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC550677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF555 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC470677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF647 conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC470677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF647 conjugate, Concentration: 0.1mg/mL |
 Antibody) H2AFX (pS2) Antibody |
|
20-abx123380 |
Abbexa |
-
EUR 594.00
-
EUR 844.80
-
EUR 260.40
-
EUR 427.20
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
 Antibody) EIF2S2 (pS2) Antibody |
|
20-abx000391 |
Abbexa |
-
EUR 594.00
-
EUR 844.80
-
EUR 427.20
|
|
|
|
 Antibody) eIF2B (pS2) Antibody |
|
abx215110-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
 Antibody) MAX (pS2) Antibody |
|
abx216735-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
pS2(GE2) Antibody |
|
BNC040677-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(GE2), CF405S conjugate, Concentration: 0.1mg/mL |
pS2(GE2) Antibody |
|
BNC040677-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(GE2), CF405S conjugate, Concentration: 0.1mg/mL |
 Anti-pS2 antibody |
|
STJ98727 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to pS2. |
 Antibody) pS2(TFF1/1091) Antibody |
|
BNCA1091-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against pS2(TFF1/1091), APC conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCAP1091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCAP1091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC611091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF660R conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC611091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF660R conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNUM1091-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against pS2(TFF1/1091), 1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCR1091-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against pS2(TFF1/1091), RPE conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNUB1091-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Concentration: 0.2mg/mL |
pS2(TFF1/1091) Antibody |
|
BNUB1091-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against pS2(TFF1/1091), Concentration: 0.2mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC431091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF543 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC431091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF543 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC051091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF405M conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC051091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF405M conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC401091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF640R conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC401091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF640R conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC811091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF680R conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC811091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF680R conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC881091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF488A conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC881091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF488A conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC801091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF680 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC801091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF680 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCH1091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCH1091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCP1091-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against pS2(TFF1/1091), PerCP conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC041091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF405S conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC041091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF405S conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC681091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF568 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC681091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF568 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC701091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF770 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC701091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF770 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCB1091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Biotin conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNCB1091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), Biotin conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC941091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF594 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC941091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF594 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC551091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF555 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC551091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF555 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC471091-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF647 conjugate, Concentration: 0.1mg/mL |
pS2(TFF1/1091) Antibody |
|
BNC471091-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against pS2(TFF1/1091), CF647 conjugate, Concentration: 0.1mg/mL |
 Antibody) Presenilin 2 (PS2) Antibody |
|
20-abx174156 |
Abbexa |
|
|
|
|
 Antibody) Histone H1 (pS2) Antibody |
|
20-abx134254 |
Abbexa |
-
EUR 460.80
-
EUR 727.20
-
EUR 276.00
|
|
|
|
Presenilin 2 (PS2) Antibody |
|
20-abx008647 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
|
Presenilin 2 (PS2) Antibody |
|
20-abx178086 |
Abbexa |
|
|
|
|
 Antibody) Histone H2A (pS2) Antibody |
|
abx215920-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
 ELISA Kit) Rabbit Presenilin 2 / PS2 (PSEN2) ELISA Kit |
|
abx362650-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
ELISA Kit) Human Estrogen-induced protein pS2(PS2)ELISA Kit |
|
CSB-E08991h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
|
|
Description: Quantitativecompetitive ELISA kit for measuring Human Estrogen-induced protein pS2 (PS2) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human Estrogen-induced protein pS2(PS2)ELISA Kit |
|
1-CSB-E08991h |
Cusabio |
-
EUR 843.60
-
EUR 5811.60
-
EUR 3084.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
|
|
Description: Quantitativecompetitive ELISA kit for measuring Human Estrogen-induced protein pS2(PS2) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
 PS2 Blocking Peptide |
|
20-abx063344 |
Abbexa |
|
|
|
|
 Estrogen Inducible Protein pS2 Antibody |
|
49675-100ul |
SAB |
100ul |
EUR 399.6 |
Estrogen Inducible Protein pS2 Antibody |
|
49675-50ul |
SAB |
50ul |
EUR 286.8 |
) pS2 Antibody (Estrogen Inducible Protein ) |
|
R30774 |
NSJ Bioreagents |
100 ug |
EUR 419 |
 ELISA Kit) Rabbit Estrogen Induced PS2 Protein (EIPS2) ELISA Kit |
|
abx362926-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 Human PS2 ELISA Kit |
|
EHP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Porcine PS2 ELISA Kit |
|
EPP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Mouse PS2 ELISA Kit |
|
EMP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Rat PS2 ELISA Kit |
|
ERP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Goat PS2 ELISA Kit |
|
EGTP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Anserini PS2 ELISA Kit |
|
EAP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Bovine PS2 ELISA Kit |
|
EBP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Canine PS2 ELISA Kit |
|
ECP0156 |
Abclonal |
96Tests |
EUR 625.2 |
 Estrogen Inducible Protein pS2 Conjugated Antibody |
|
C49675 |
SAB |
100ul |
EUR 476.4 |
 Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
R31880 |
NSJ Bioreagents |
100 ug |
EUR 419 |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
R32898 |
NSJ Bioreagents |
100 ug |
EUR 419 |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
RQ5039 |
NSJ Bioreagents |
100ul |
EUR 419 |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V8111-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V8111-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V8111SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
RQ6909 |
NSJ Bioreagents |
100ug |
EUR 419 |
|
Description: TFF1 (Trefoil factor 1), also known as pS2, is a protein that in humans is encoded by the TFF1 gene. Members of the trefoil family are characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfides. They are stable secretory proteins expressed in gastrointestinal mucosa. Their functions are not defined, but they may protect the mucosa from insults, stabilize the mucus layer, and affect healing of the epithelium. It is found that TFF1 in normal human urine inhibited the growth of calcium oxalate crystals. Urinary TFF1 showed an inhibitory potency similar to that of nephrocalcin, and inhibition was dose dependent and inhibited by TFF1 antisera, particularly by antisera directed to the TFF1 C terminus. Concentrations and relative amounts of TFF1 in the urine of patients with idiopathic calcium oxalate kidney stones were significantly less than those found in controls. This gene, which is expressed in the gastric mucosa, has also been studied because of its expression in human tumors. This gene and two other related trefoil family member genes are found in a cluster on chromosome 21. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2259-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This antibody recognizes a polypeptide of ~6.5kDa, identified as Estrogen Inducible Protein pS2. The antibody's epitope is localized between amino acids 57-84. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain. Estrogen Inducible Protein pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for estrogen inducible protein pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that estrogen inducible protein pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2259-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This antibody recognizes a polypeptide of ~6.5kDa, identified as Estrogen Inducible Protein pS2. The antibody's epitope is localized between amino acids 57-84. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain. Estrogen Inducible Protein pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for estrogen inducible protein pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that estrogen inducible protein pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2259IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This antibody recognizes a polypeptide of ~6.5kDa, identified as Estrogen Inducible Protein pS2. The antibody's epitope is localized between amino acids 57-84. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain. Estrogen Inducible Protein pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for estrogen inducible protein pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that estrogen inducible protein pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2259SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This antibody recognizes a polypeptide of ~6.5kDa, identified as Estrogen Inducible Protein pS2. The antibody's epitope is localized between amino acids 57-84. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intrachain disulfide bonds, forming the trefoil motif, or P-domain. Estrogen Inducible Protein pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for estrogen inducible protein pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that estrogen inducible protein pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2879-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2879-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2879IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2879SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2880-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2880-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2880IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V2880SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. Its epitope is located in the c-terminus of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7165-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TFF1/Breast cancer estrogen inducible protein pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. TFF1/pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. TFF1 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7165-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TFF1/Breast cancer estrogen inducible protein pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. TFF1/pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. TFF1 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7165IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: TFF1/Breast cancer estrogen inducible protein pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. TFF1/pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. TFF1 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7165SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TFF1/Breast cancer estrogen inducible protein pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. TFF1/pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. TFF1 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7354-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7354-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7354IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7354SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7460-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7460-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7460IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V7460SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V9082-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V9082-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V9082IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
Estrogen Inducible Protein pS2 / TFF1 Antibody |
|
V9082SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: It recognizes a polypeptide of 6.5kDa, identified as pS2 estrogen-regulated protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60% of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. It is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy. |
 Anti-Estrogen Inducible Protein pS2/Tff1 Antibody |
|
A01391 |
BosterBio |
100ug/vial |
EUR 352.8 |
 Anti-Estrogen Inducible Protein pS2 Monoclonal Antibody |
|
M01391-1 |
BosterBio |
100ug |
EUR 476.4 |
|
Description: Rabbit Monoclonal Estrogen Inducible Protein pS2 Antibody. Validated in IP, IF, WB and tested in Human. |
 Anti-Estrogen Inducible Protein pS2/TFF1 Antibody |
|
PA1689 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-Estrogen Inducible Protein pS2/TFF1 Antibody |
|
PA1690 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-Estrogen Inducible Protein pS2/TFF1 Antibody |
|
PB9522 |
BosterBio |
100ug/vial |
EUR 352.8 |
 Protein) Rat Presenilin 2 (PS2) Protein |
|
20-abx654797 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Guinea Pig PS2 ELISA Kit |
|
EGP0156 |
Abclonal |
96Tests |
EUR 625.2 |
Rat Presenilin 2 (PS2) ELISA Kit |
|
SEB274Ra-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5850.59 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Presenilin 2 (PS2) in Tissue homogenates and other biological fluids. |
Rat Presenilin 2 (PS2) ELISA Kit |
|
SEB274Ra-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 586.99 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Presenilin 2 (PS2) in Tissue homogenates and other biological fluids. |
Rat Presenilin 2 (PS2) ELISA Kit |
|
SEB274Ra-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 787.13 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Presenilin 2 (PS2) in Tissue homogenates and other biological fluids. |
Rat Presenilin 2 (PS2) ELISA Kit |
|
SEB274Ra-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3182.08 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Presenilin 2 (PS2) in Tissue homogenates and other biological fluids. |
Rat Presenilin 2 (PS2) ELISA Kit |
|
4-SEB274Ra |
Cloud-Clone |
-
EUR 5911.20
-
EUR 3122.40
-
EUR 787.20
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Presenilin 2 (PS2) in samples from Tissue homogenates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
) Anti-Estrogen Inducible Protein pS2 (M1) |
|
YF-MA15828 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to Estrogen Inducible Protein pS2 |
) Anti-Estrogen Inducible Protein pS2 (M2) |
|
YF-MA15829 |
Abfrontier |
50 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to Estrogen Inducible Protein pS2 |
Anti-Estrogen Inducible Protein pS2 (M2) |
|
YF-MA15830 |
Abfrontier |
200 ul |
EUR 435.6 |
|
Description: Mouse monoclonal to Estrogen Inducible Protein pS2 |
) Anti-Estrogen Inducible Protein pS2 (3H5) |
|
YF-MA10930 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to Estrogen Inducible Protein pS2 |
 Antibody) MYC Associated Factor X Phospho-Ser2 (MAX pS2) Antibody |
|
20-abx326647 |
Abbexa |
|
|
|
|
pS2 Rabbit Polyclonal Antibody
